Research agreement with leading pharmaceutical company

February 29, 2012

CALIXAR sign a research agreement with big pharma for isolating and purifying complex membrane protein target involved in obesity and diabete

DATES : 29/02/2012

Share this post

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.